Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

Profitable Trading Secrets Revealed in INTC, DIS, MU and MRK

Marketwired August 13, 2013

In the Know, Smart Investing in V, MRK, TWX and HAL

Marketwired August 9, 2013

Special Situation Coming Soon, a Look Inside CELG, MRK, EBAY and MON

Marketwired August 8, 2013

Special Offer for Shareholders of ITUB, MRK, STXS and SVU

Marketwired August 7, 2013

Secrets to Making Money in SLB, MCD and MRK

Marketwired August 6, 2013

Strategy Behind Our Success, We Get in Early: FOXA, CMCSA, WMB and MRK

Marketwired August 2, 2013

The Straight Truth, Investing in MRK and JPM

Marketwired August 1, 2013

Merck and Her Campus Ask College-Aged Women to Take the Pledge to Plan It Forward For Their Futures by Evaluating How Today's Decisions Can Affect Tomorrow

PR Newswire August 1, 2013

The Real Story Behind MRK, GT, BP and ITUB

Marketwired July 31, 2013

Before the Crowd, How We Found MRK, GILD, KO and JPM

Marketwired July 30, 2013

Merck Announces Second-Quarter 2013 Financial Results

Business Wire July 30, 2013

Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness

Business Wire July 29, 2013

Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin

Business Wire July 26, 2013

Key to Success, How to Profit: EBAY, SPF, XOM and MRK

Marketwired July 26, 2013

The Reason It Trades, What's Moving PG, MRK, AXP and F

Marketwired July 25, 2013

Perfect Trade Setups, How to Play MRK, TSM, WAG and FB

Marketwired July 25, 2013

Merck Announces Fourth-Quarter 2013 Dividend

Business Wire July 24, 2013

Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine

Business Wire July 24, 2013

Merck Statement on FDA Advisory Committee Meeting About Sugammadex Sodium Injection

Business Wire July 16, 2013

Dr. Avtar Dhillon Leads Arch Therapeutics (ARTH) After Successful Positions With ONCS and INO

Marketwired July 15, 2013